United States · Who invested in Rapamycin Holdings?
Rapamycin Holdings's investors include UT Horizon Fund and The Texas Technology Development Center.
201320142015
?Seed$616KDebt$1.4MDebt$2.5MSeries AUnited States · Series A startup
Who invested in Rapamycin Holdings
4 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$4.5Mraised across 4 rounds since 2012, from 4 sources
$616KDebt$1.4MDebt$2.5MSeries A
- Latest round
- Series A, $2.5MJun 2015
- Step-upi
- 1.8×
- Investors
- 2
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Seed Dec 2012
- Biggest round
- $2.5M Series A · Jun 2015
- Usual gap between rounds
- 7 months the median of 3
The rounds
- Jun 2015Series A$2.5M
No investor was named in the report.
From a historical funding record
- Feb 2014Debt$1.4M
No investor was named in the report.
From a historical funding recordSEC filing: $1.4M sold, first sale Jul 2013
- Jul 2013
- Dec 2012SeedAmount undisclosed2 new
- UT Horizon Fund
- The Texas Technology Development Center
From a historical funding record
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Quick answers about Rapamycin Holdings
How much has Rapamycin Holdings raised?
Rapamycin Holdings has raised $4.5M across 4 rounds since 2012. One round did not disclose an amount, so the total is a floor.
When did Rapamycin Holdings last raise?
Rapamycin Holdings's most recent round was a Series A of $2.5M in Jun 2015.
What was Rapamycin Holdings's biggest round?
Its most recent round, $2.5M in Jun 2015, is also its largest on record.
Who backed Rapamycin Holdings first?
Rapamycin Holdings's first round on record, in Dec 2012, was backed by UT Horizon Fund and The Texas Technology Development Center.
What stage is Rapamycin Holdings at?
Rapamycin Holdings's latest named round is a Series A, in Jun 2015.
Where is Rapamycin Holdings based?
Rapamycin Holdings is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.